Biotech · Public company · Aliso Viejo, CA, US

AEON Biopharma, Inc.

Ticker AEON · SEC CIK 0001837607

Track this companyFree. Adds AEON Biopharma, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs2From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline2

Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine PreventionPHASE2 · TERMINATED · started Oct 19, 2021ClinicalTrials.gov NCT05016661 · fetched Nov 12, 2026
Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical DystoniaPHASE2 · COMPLETED · started Jul 27, 2021ClinicalTrials.gov NCT04871451 · fetched Nov 12, 2026
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical DystoniaPHASE2 · COMPLETED · started Mar 29, 2021ClinicalTrials.gov NCT04849988 · fetched Nov 12, 2026
Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in AdultsPHASE2 · COMPLETED · started Mar 1, 2021ClinicalTrials.gov NCT04845178 · fetched Nov 12, 2026